PharmGKB summary-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PharmGKB summary

Published:2017-08 Issue:8 Volume:27 Page:307-312
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Thorn Caroline F.,Sharma Manish R.,Altman Russ B.,Klein Teri E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference41 articles.

1. Pazopanib for the treatment of metastatic renal cell carcinoma;Pick;Clin Ther,2012

2. Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: a new treatment for metastatic soft tissue sarcoma;Ranieri;Crit Rev Oncol Hematol,2014

3. Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma;Sonpavde;Expert Opin Investig Drugs,2008

4. Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity;Kumar;Mol Cancer Ther,2007

5. Vascular endothelial growth factor pathway;Maitland;Pharmacogenet Genomics,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium citrate buffer improves pazopanib solubility and absorption in gastric acid-suppressed rat model;Drug Metabolism and Pharmacokinetics;2024-04

2. Elderberry interaction with pazopanib in a patient with soft‑tissue sarcoma: A case report and literature review;Molecular and Clinical Oncology;2024-03-20

3. Pharmacogenomic Biomarkers;Biomarkers in Medicine;2022-08-30

4. Pharmacokinetics and Bioequivalence of a Generic and a Branded Pazopanib Tablet in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2022-04-05

5. CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation?;Frontiers in Genetics;2021-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3